{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:48:00Z","timestamp":1792043280390,"version":"4.4.0"},"reference-count":49,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["22\u20109"],"award-info":[{"award-number":["22\u20109"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Geriatrics Gerontology Int"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>B\u2010type natriuretic peptide (BNP) has been identified as a biomarker of sarcopenia in community\u2010dwelling populations and in patients with heart failure. However, it remains unclear whether BNP is associated with sarcopenia in the pre\u2010heart failure stage in older adults with cardiometabolic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross\u2010sectional study, BNP was measured in 697 older outpatients with cardiometabolic disease and no history of heart failure or atrial fibrillation. Sarcopenia was assessed using the Asian Working Group for Sarcopenia criteria 2019. The participants were grouped according to whether their BNP level was &lt;\u200935\u2009pg\/mL, 35\u2009\u2264\u2009BNP\u2009&lt;\u2009100\u2009pg\/mL, or\u2009\u2265\u2009100\u2009pg\/mL in accordance with the Japanese guideline on diagnosis and treatment of heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 78.8\u2009\u00b1\u20096.8\u2009years. Sarcopenia was present in 38% of patients. Natural log\u2010transformed BNP was significantly related to gait speed (\n                      <jats:italic>B<\/jats:italic>\n                      \u2009=\u2009\u20130.278, SE\u2009=\u20090.128,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) and hand grip strength (\n                      <jats:italic>B<\/jats:italic>\n                      \u2009=\u2009\u22120.016, SE\u2009=\u20090.007,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013) even after adjusting for age, sex, body mass index, estimated glomerular filtration rate, regular alcohol intake, smoking status, diabetes mellitus, dyslipidemia, hypertension, stroke, and antihypertensive medication use. Multivariate logistic regression analysis revealed that those with BNP\u2009\u2265\u2009100\u2009pg\/mL had an increased risk of sarcopenia (OR 2.33, 95% CI 1.18\u20134.60), low appendicular skeletal mass index (OR 2.47, 95% CI 1.19\u20135.15), and low handgrip strength (OR 2.44, 95% CI 1.27\u20134.68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased BNP (\u2265\u2009100\u2009pg\/mL) was associated with sarcopenia even in individuals with cardiometabolic disease and no history of atrial fibrillation or symptomatic heart failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ggi.70868","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:18:08Z","timestamp":1792041488000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["B\u2010Type Natriuretic Peptide Is Associated With Sarcopenia in Older Patients Without Symptomatic Heart Failure"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-6092","authenticated-orcid":false,"given":"Ayumi","family":"Toba","sequence":"first","affiliation":[{"name":"Department of Cardiology Tokyo Metropolitan Institute for Geriatrics and Gerontology  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-815X","authenticated-orcid":false,"given":"Joji","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology Tokyo Metropolitan Institute for Geriatrics and Gerontology  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-3319","authenticated-orcid":false,"given":"Yoshiaki","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism, and Endocrinology Tokyo Metropolitan Institute for Geriatrics and Gerontology  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism, and Endocrinology Tokyo Metropolitan Institute for Geriatrics and Gerontology  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0535-6631","authenticated-orcid":false,"given":"Kazumasa","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Cardiology Tokyo Metropolitan Institute for Geriatrics and Gerontology  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the Art: Using Natriuretic Peptide Levels in Clinical Practice","volume":"10","author":"Maisel A.","year":"2008","journal-title":"European Journal of Heart Failure"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ejhf.2848","article-title":"Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"25","author":"Tsutsui H.","year":"2023","journal-title":"European Journal of Heart Failure"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological Blood Pressure Lowering for Primary and Secondary Prevention of Cardiovascular Disease Across Different Levels of Blood Pressure: An Individual Participant\u2010Level Data Meta\u2010Analysis","volume":"397","author":"Rahimi K.","year":"2021","journal-title":"Lancet"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.0000170140.36633.8f","article-title":"Effect of Compensated Renal Dysfunction on Approved Heart Failure Markers: Direct Comparison of Brain Natriuretic Peptide (BNP) and N\u2010Terminal Pro\u2010BNP","volume":"46","author":"Luchner A.","year":"2005","journal-title":"Hypertension"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archsurg.2007.69","article-title":"B\u2010Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock","volume":"143","author":"Kandil E.","year":"2008","journal-title":"Archives of Surgery"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41440-024-01998-9","article-title":"Resistance Exercise Has an Antihypertensive Effect Comparable to That of Aerobic Exercise in Hypertensive Patients: A Meta\u2010Analysis of Randomized Controlled Trials","volume":"48","author":"Morita H.","year":"2025","journal-title":"Hypertension Research"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ejhf.1926","article-title":"Prevalence and Prognostic Impact of the Coexistence of Multiple Frailty Domains in Elderly Patients With Heart Failure: The FRAGILE\u2010HF Cohort Study","volume":"22","author":"Matsue Y.","year":"2020","journal-title":"European Journal of Heart Failure"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment","volume":"21","author":"Chen L. K.","year":"2020","journal-title":"Journal of the American Medical Directors Association"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ehf2.13255","article-title":"Sarcopenia in Heart Failure: A Systematic Review and Meta\u2010Analysis","volume":"8","author":"Zhang Y.","year":"2021","journal-title":"ESC Heart Failure"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s41999-024-00950-x","article-title":"Sarcopenia Is Linked to Higher Levels of B\u2010Type Natriuretic Peptide and Its N\u2010Terminal Fragment in Heart Failure: A Systematic Review and Meta\u2010Analysis","volume":"15","author":"Prokopidis K.","year":"2024","journal-title":"European Geriatric Medicine"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40520-024-02713-x","article-title":"Association Between Natriuretic Peptides and C\u2010Reactive Protein With Frailty in Heart Failure: A Systematic Review and Meta\u2010Analysis","volume":"36","author":"Prokopidis K.","year":"2024","journal-title":"Aging Clinical and Experimental Research"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1253\/circrep.CR-25-0110","article-title":"Association Between Serum N\u2010Terminal Prohormone of Brain Natriuretic Peptide (NT\u2010proBNP) Levels and Frailty in Community\u2010Dwelling Old\u2010Old Older Adults \u2010 SONIC Study","volume":"7","author":"Terada S.","year":"2025","journal-title":"Circulation Reports"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12603-018-1112-7","article-title":"Association of BNP With Frailty in Elderly Population: Rugao Longevity and Ageing Study","volume":"23","author":"Yao S.","year":"2019","journal-title":"Journal of Nutrition, Health & Aging"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12877-018-0955-4","article-title":"Prevalence of Frailty, Cognitive Impairment, and Sarcopenia in Outpatients With Cardiometabolic Disease in a Frailty Clinic","volume":"18","author":"Tamura Y.","year":"2018","journal-title":"BMC Geriatrics"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1447-0594.2010.00585.x","article-title":"Brief Screening Tool for Mild Cognitive Impairment in Older Japanese: Validation of the Japanese Version of the Montreal Cognitive Assessment","volume":"10","author":"Fujiwara Y.","year":"2010","journal-title":"Geriatrics & Gerontology International"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3810\/pgm.2009.03.1990","article-title":"Computer Assessment of Mild Cognitive Impairment","volume":"121","author":"Saxton J.","year":"2009","journal-title":"Postgraduate Medicine"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ggi.12543","article-title":"Validity of the Kihon Checklist for Assessing Frailty Status","volume":"16","author":"Satake S.","year":"2016","journal-title":"Geriatrics & Gerontology International"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/ggi.14005","article-title":"The Revised Japanese Version of the Cardiovascular Health Study Criteria (Revised J\u2010CHS Criteria)","volume":"20","author":"Satake S.","year":"2020","journal-title":"Geriatrics & Gerontology International"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jdi.13306","article-title":"Japanese Clinical Practice Guideline for Diabetes 2019","volume":"11","author":"Araki E.","year":"2020","journal-title":"Journal of Diabetes Investigation"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.GL2017","article-title":"Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017","volume":"25","author":"Kinoshita M.","year":"2018","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura S.","year":"2019","journal-title":"Hypertension Research: Official Journal of the Japanese Society of Hypertension"},{"key":"e_1_2_12_23_1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/ggi.14975","article-title":"DASC\u201021 Score and Risk of Rehospitalization and All\u2010Cause Mortality After Discharge in Older Patients With Heart Failure","volume":"24","author":"Shimizu R.","year":"2024","journal-title":"Geriatrics & Gerontology International"},{"key":"e_1_2_12_24_1","first-page":"135","article-title":"Frailty and Healthcare Utilization Among Patients With Heart Failure in the Community","volume":"1","author":"McNallan S. M.","year":"2013","journal-title":"JACC: Heart Failure"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ahj.2013.07.008","article-title":"Measuring Frailty in Heart Failure: A Community Perspective","volume":"166","author":"McNallan S. M.","year":"2013","journal-title":"American Heart Journal"},{"key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The Prevalence of Frailty in Heart Failure: A Systematic Review and Meta\u2010Analysis","volume":"236","author":"Denfeld Q. E.","year":"2017","journal-title":"International Journal of Cardiology"},{"key":"e_1_2_12_27_1","first-page":"608","article-title":"Plasma Brain Natriuretic Peptide Level in Older Outpatients With Heart Failure Is Associated With Physical Frailty, Especially With the Slowness Domain","volume":"13","author":"Nishiguchi S.","year":"2016","journal-title":"Journal of Geriatric Cardiology: JGC"},{"key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurjpc\/zwaa117","article-title":"Impact of Sarcopenia on Prognosis in Patients With Heart Failure With Reduced and Preserved Ejection Fraction","volume":"28","author":"Konishi M.","year":"2021","journal-title":"European Journal of Preventive Cardiology"},{"key":"e_1_2_12_29_1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1253\/circj.CJ-25-0002","article-title":"JCS\/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure","volume":"89","author":"Kitai T.","year":"2025","journal-title":"Circulation Journal"},{"key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ehf2.14947","article-title":"Systemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues","volume":"12","author":"Fang Z.","year":"2025","journal-title":"ESC Heart Failure"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle Wasting and Cachexia in Heart Failure: Mechanisms and Therapies","volume":"14","author":"Haehling S.","year":"2017","journal-title":"Nature Reviews Cardiology"},{"key":"e_1_2_12_32_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2016.04.128","article-title":"A Simple Sarcopenia Screening Test Predicts Future Adverse Events in Patients With Heart Failure","volume":"215","author":"Onoue Y.","year":"2016","journal-title":"International Journal of Cardiology"},{"key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1536\/ihj.17-057","article-title":"Significance of Sarcopenia Evaluation in Acute Decompensated Heart Failure","volume":"59","author":"Tsuchida K.","year":"2018","journal-title":"International Heart Journal"},{"key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1532-5415.2009.02078.x","article-title":"Plasma Brain Natriuretic Peptide Measured in Stable Conditions Is Related to Mortality in Frail and Very Old Patients","volume":"57","author":"Lebourgeois F.","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9343(02)01525-5","article-title":"Prognostic Value of High Plasma Brain Natriuretic Peptide Concentrations in Very Elderly Persons","volume":"114","author":"Ueda R.","year":"2003","journal-title":"American Journal of Medicine"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjcard.2007.11.029","article-title":"Amino\u2010Terminal Pro\u2010B\u2010Type Natriuretic Peptide Testing in Renal Disease","volume":"101","author":"DeFilippi C.","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2261-12-57","article-title":"Association of Cardiac and Renal Function With Extreme N\u2010Terminal Fragment Pro\u2010B\u2010Type Natriuretic Peptide Levels in Elderly Patients","volume":"12","author":"Cui H.","year":"2012","journal-title":"BMC Cardiovascular Disorders"},{"key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma Brain Natriuretic Peptide Concentration: Impact of Age and Gender","volume":"40","author":"Redfield M. M.","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"key":"e_1_2_12_39_1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of Neuroendocrine Activation in Patients With Left Ventricular Dysfunction With and Without Congestive Heart Failure. A Substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis G. S.","year":"1990","journal-title":"Circulation"},{"key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"e006541","DOI":"10.1161\/CIRCHEARTFAILURE.119.006541","article-title":"Comparison of BNP and NT\u2010proBNP in Patients With Heart Failure and Reduced Ejection Fraction","volume":"13","author":"R\u00f8rth R.","year":"2020","journal-title":"Circulation. Heart Failure"},{"key":"e_1_2_12_41_1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/ehf2.14894","article-title":"Setting the Optimal Threshold of NT\u2010proBNP and BNP for the Diagnosis of Heart Failure in Patients Over 75\u2009Years","volume":"11","author":"Berthelot E.","year":"2024","journal-title":"ESC Heart Failure"},{"key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ehf2.14274","article-title":"Prevalence and Prognosis of Frailty in Older Patients With Stage B Heart Failure With Preserved Ejection Fraction","volume":"10","author":"Meng C.","year":"2023","journal-title":"ESC Heart Failure"},{"key":"e_1_2_12_43_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12877-021-02072-6","article-title":"Frailty Related All\u2010Cause Mortality or Hospital Readmission Among Adults Aged 65 and Older With Stage\u2010B Heart Failure Inpatients","volume":"21","author":"Zheng P. P.","year":"2021","journal-title":"BMC Geriatrics"},{"key":"e_1_2_12_44_1","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1111\/jgs.70046","article-title":"Prevalence and Prognostic Implication of Sarcopenia Among Patients With Stage B Heart Failure: The PAPRIKA\u2010HF Cohort Study","volume":"73","author":"Matsumura K.","year":"2025","journal-title":"Journal of the American Geriatrics Society"},{"key":"e_1_2_12_45_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1507\/endocrj.EJ19-0024","article-title":"High Brain Natriuretic Peptide Is Associated With Sarcopenia in Patients With Type 2 Diabetes: A Cross\u2010Sectional Study of KAMOGAWA\u2010DM Cohort Study","volume":"66","author":"Okamura T.","year":"2019","journal-title":"Endocrine Journal"},{"key":"e_1_2_12_46_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of Muscle Atrophy and Hypertrophy: Implications in Health and Disease","volume":"12","author":"Sartori R.","year":"2021","journal-title":"Nature Communications"},{"key":"e_1_2_12_47_1","doi-asserted-by":"crossref","first-page":"e70109","DOI":"10.1002\/jcsm.70109","article-title":"Role of Peptides in Skeletal Muscle Wasting: A Scoping Review","volume":"16","author":"Naumovski P.","year":"2025","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fphys.2020.00963","article-title":"Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging","volume":"11","author":"Correa\u2010de\u2010Araujo R.","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"e_1_2_12_49_1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41440-022-01157-y","article-title":"Association Between Hypertension and Myosteatosis Evaluated by Abdominal Computed Tomography","volume":"46","author":"Jung H. N.","year":"2023","journal-title":"Hypertension Research"},{"key":"e_1_2_12_50_1","doi-asserted-by":"crossref","first-page":"e012116","DOI":"10.1161\/CIRCIMAGING.120.012116","article-title":"Association Between Myocardial Strain and Frailty in CHS","volume":"14","author":"Tan A. X.","year":"2021","journal-title":"Circulation. Cardiovascular Imaging"}],"container-title":["Geriatrics &amp; Gerontology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ggi.70868","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ggi.70868","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ggi.70868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:18:14Z","timestamp":1792041494000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ggi.70868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/ggi.70868"],"URL":"https:\/\/doi.org\/10.1111\/ggi.70868","archive":["Portico"],"relation":{},"ISSN":["1444-1586","1447-0594"],"issn-type":[{"value":"1444-1586","type":"print"},{"value":"1447-0594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70868"}}